Different Methods and Formulations of Drugs and Vaccines for Nasal Administration
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Tai, Junhu | - |
dc.contributor.author | Han, Munsoo | - |
dc.contributor.author | Lee, Dabin | - |
dc.contributor.author | Park, Il-Ho | - |
dc.contributor.author | Lee, Sang Hag | - |
dc.contributor.author | Kim, Tae Hoon | - |
dc.date.accessioned | 2022-06-22T16:41:19Z | - |
dc.date.available | 2022-06-22T16:41:19Z | - |
dc.date.created | 2022-06-22 | - |
dc.date.issued | 2022-05 | - |
dc.identifier.issn | 1999-4923 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/142281 | - |
dc.description.abstract | Nasal drug delivery is advantageous when compared with other routes of drug delivery as it avoids the hepatic first-pass effect, blood-brain barrier penetration, and compliance issues with parenteral administration. However, nasal administration also has some limitations, such as its low bioavailability due to metabolism on the mucosal surface, and irreversible damage to the nasal mucosa due to the ingredients added into the formula. Moreover, the method of nasal administration is not applicable to all drugs. The current review presents the nasal anatomy and mucosal environment for the nasal delivery of vaccines and drugs, as well as presents various methods for enhancing nasal absorption, and different drug carriers and delivery devices to improve nasal drug delivery. It also presents future prospects on the nasal drug delivery of vaccines and drugs. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | MDPI | - |
dc.subject | PROTECTIVE IMMUNE-RESPONSE | - |
dc.subject | INTRANASAL DELIVERY | - |
dc.subject | INFLUENZA-VIRUS | - |
dc.subject | BRAIN DELIVERY | - |
dc.subject | QUANTUM DOTS | - |
dc.subject | LIPID NANOPARTICLES | - |
dc.subject | ALLERGIC RHINITIS | - |
dc.subject | CARBON NANOTUBES | - |
dc.subject | MUCOSAL VACCINES | - |
dc.subject | CONTROLLED-TRIAL | - |
dc.title | Different Methods and Formulations of Drugs and Vaccines for Nasal Administration | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Park, Il-Ho | - |
dc.contributor.affiliatedAuthor | Kim, Tae Hoon | - |
dc.identifier.doi | 10.3390/pharmaceutics14051073 | - |
dc.identifier.scopusid | 2-s2.0-85130759613 | - |
dc.identifier.wosid | 000802370700001 | - |
dc.identifier.bibliographicCitation | PHARMACEUTICS, v.14, no.5 | - |
dc.relation.isPartOf | PHARMACEUTICS | - |
dc.citation.title | PHARMACEUTICS | - |
dc.citation.volume | 14 | - |
dc.citation.number | 5 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | PROTECTIVE IMMUNE-RESPONSE | - |
dc.subject.keywordPlus | INTRANASAL DELIVERY | - |
dc.subject.keywordPlus | INFLUENZA-VIRUS | - |
dc.subject.keywordPlus | BRAIN DELIVERY | - |
dc.subject.keywordPlus | QUANTUM DOTS | - |
dc.subject.keywordPlus | LIPID NANOPARTICLES | - |
dc.subject.keywordPlus | ALLERGIC RHINITIS | - |
dc.subject.keywordPlus | CARBON NANOTUBES | - |
dc.subject.keywordPlus | MUCOSAL VACCINES | - |
dc.subject.keywordPlus | CONTROLLED-TRIAL | - |
dc.subject.keywordAuthor | drug delivery | - |
dc.subject.keywordAuthor | intranasal | - |
dc.subject.keywordAuthor | vaccine | - |
dc.subject.keywordAuthor | immunity | - |
dc.subject.keywordAuthor | nanotechnology | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.